Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Infectious bronchitis virus (IBV) is a highly contagious avian Gammacoronavirus that primarily infects chickens, causing acute respiratory disease, reduced egg production and quality, nephritis, and sometimes mortality. It is characterized by high genetic variability due to high mutation rates and frequent recombination events, especially within the S1 gene. Control measures mainly rely on vaccines, but their effectiveness is limited by the virus's antigenic diversity. The S glycoprotein is a key determinant of serotype and is the target of neutralizing antibodies.
Vaccine-induced antibody neutralization of the virus.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Infectious Bronchitis Virus (IBV).